Showing results (11-20 of 1,269) with videos related to

Sort By:
Pageof 127
International Journal of Molecular Sciences|February 25, 2023
Graft-versus-Host Disease Modulation by Innate T CellsYing Fang, Yichen Zhu, Adam Kramer, et al.
ACS Nano|April 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer TherapyCitradewi Soemardy, Yan-Ruide Li, Yichen Zhu, et al.
Cell Reports. Medicine|November 19, 2025
From bench to body: In vivo CAR engineering in the clinicYan-Ruide Li, Lili Yang
Experimental Hematology & Oncology|July 4, 2026
Advances in antibody-drug conjugates in cancer: latest updates from the 2026 AACR annual meetingYan-Ruide Li, Yichen Zhu, Yuning Chen
Trends in Pharmacological Sciences|November 26, 2025
Autologous, allogeneic, in vivo CAR for autoimmune diseasesYan-Ruide Li, Lili Yang
STAR Protocols|January 14, 2026
Protocol to generate human stem cell-derived CD70-directed allogeneic CAR-NKT cells for treating renal cell carcinomaYan-Ruide Li, Lili Yang
Leukemia|March 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemiaYan-Ruide Li, Xinyuan Shen, Yuning Chen, et al.
Frontiers in Medicine|April 17, 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapyYuning Chen, Yichen Zhu, Adam Kramer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2022
Mucosal-associated invariant T cells for cancer immunotherapyYan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy Oncolytics|October 25, 2023
Advancements in CRISPR screens for the development of cancer immunotherapy strategiesYan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Pageof 127